CHRS News and Press, Coherus BioSciences Inc. From 01/10/24

2024-01-10 07:24:49 ET More on Coherus BioSciences Coherus BioSciences Is A Buy On The Dip After Toripalimib Approval Coherus: The Surface Acquisition Is A Distraction Coherus BioSciences, Inc. (CHRS) Q3 2023 Earnings Call Transcript Coherus gets FDA approval...

2024-01-05 14:00:38 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Inovio Pharmaceuticals, Inc. (INO) Q3 2023 Earnings Call Transcript Inovio plans to submit BLA to FDA for INO-3107 in 2H Bank of ...

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi) PR Newswire - Combination therapy to be evaluated in a Phase 3 trial in patients with locoregionally advanc...

REDWOOD CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” Nasdaq: CHRS), today announced that senior management will present at the upcoming 42 nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:45 a.m. Pacifi...

– Launch of LOQTORZI offers first and only FDA-approved treatment for NPC in all lines of therapy – – Indicated in combination with chemotherapy for 1 st line treatment and as monotherapy for patients with disease progression on or after platinum co...

2023-12-28 15:45:29 ET Shares of Coherus BioSciences (NASDAQ: CHRS) are up 19.7% as of 3:20 p.m. ET Thursday after the U.S. Food and Drug Administration (FDA) approved Udenyca OnBody, the company's on-body injection system that can be taken to prevent infection in chemotherapy patie...

2023-12-28 12:22:59 ET DENVER, Colo., Dec. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; SEALSQ Corp (NASDAQ: LAES), Microbot Medical Inc (NASDAQ: MBOT), Nova Lifestyle Inc (NASDAQ: NVFY), Se...

2023-12-27 13:19:00 ET U.S. stocks on Wednesday made small moves , amid trading that is expected to be thin with many investors on holiday. Equities had kicked off the final week of the year on a positive note in the previous session. Here are some of Wednesday's biggest stock mover...

2023-12-27 12:29:36 ET More on AbbVie, Johnson & Johnson, etc. Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) AbbVie Vs. GSK: Dual Dominance In Pharma ...

2023-12-27 12:23:36 ET DENVER, Colo., Dec. 27, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; First Wave BioPharma Inc (NASDAQ: FWBI), Coherus BioSciences Inc (NASDAQ: CHRS), Cingulate Inc (NASDAQ...